The gut microbiota as a novel nutritional target to influence systemic inflammation associated with prevalent health disorders
Year: 2023
Type: dissertation
Abstract: Systemic inflammation is an underlying symptom present in many diseases including Asthma and Obesity. This inflammation may arise internally with the release of pro inflammatory adipokines such as asprosin, or through increased gut permeability which allows endotoxin, derived from gram-negative bacteria, to cross into the bloodstream and mediate an innate immune inflammatory response. Both asprosin and endotoxin are elevated in conditions of metabolic disease, which share a similar inflammatory profile with Asthma. Currently, Asthma treatments relieve symptoms rather than targeting the trigger that causes the inflammation. Therefore, to target the source of the inflammation, the use of internally derived anti-inflammatory agents, such as short chain fatty acids (SCFAs) may provide a therapeutic answer. SCFAs are produced from the metabolism of dietary substrates (e.g. prebiotics) by the gut microbiota, which appear to provide anti-inflammatory health benefits systemically as well as locally. \n \nTherefore, a series of studies addressed the role of SCFAs (acetate, butyrate, and propionate) on endotoxin- and asprosin-induced inflammation in models of Asthma and Obesity using human bronchial epithelial cells and human white adipocyte cells to assess their impact on metabolism. Molecular techniques including Western blot and RT-qPCR, and mitochondrial dynamic analysis were explored to examine metabolism. Furthermore, a human invention trial was conducted to evaluate the use of prebiotics to improve inflammation, lung function, and Asthma symptoms in participants. \n \nThe outcomes of these in vitro studies suggest that SCFAs have the capacity to mitigate endotoxin and asprosin induced inflammation in airway and adipocyte cells. Whilst in vivo studies, where participants with Asthma were given a prebiotic supplementation, showed improvements in serum metabolic markers in. Taken together, these data suggest that increasing SCFA production through dietary interventions may provide a novel management tool to relieve cellular inflammatory damage in patients with Asthma or Obesity-related Asthma to potentially relieve Asthma symptoms over time.
Author: Lad, N
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W6982104400
